BioStock: Saniona on the equity and milestone upside in the AstronauTx deal
18 augusti, 09:15
18 augusti, 09:15
AstronauTx has exercised its option to acquire worldwide rights to a joint neurological disease programme, which has yielded the development candidate ATX0926. Saniona receives USD 5 million in AstronauTx shares and keeps potential milestone and royalty payments on top. BioStock contacted Saniona’s CEO Thomas Feldthus for comment.
Read the full interview at biostock.se:
Saniona on the equity and milestone upside in the AstronauTx deal
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Read the latest news, keep track of upcoming events, explore BioStock Analytics' in-depth analyses and watch the latest videos! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the Nordic region's leading information channel for life science. Focusing on biotech, medtech, diagnostics and pharmaceutical development, we provide daily news updates, in-depth analyses via BioStock Analytics, exclusive interviews and innovation-driving networking events – all to keep you up to date on developments in the sector.
BioStock – Connecting Innovation & Capital.
18 augusti, 09:15
AstronauTx has exercised its option to acquire worldwide rights to a joint neurological disease programme, which has yielded the development candidate ATX0926. Saniona receives USD 5 million in AstronauTx shares and keeps potential milestone and royalty payments on top. BioStock contacted Saniona’s CEO Thomas Feldthus for comment.
Read the full interview at biostock.se:
Saniona on the equity and milestone upside in the AstronauTx deal
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Read the latest news, keep track of upcoming events, explore BioStock Analytics' in-depth analyses and watch the latest videos! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the Nordic region's leading information channel for life science. Focusing on biotech, medtech, diagnostics and pharmaceutical development, we provide daily news updates, in-depth analyses via BioStock Analytics, exclusive interviews and innovation-driving networking events – all to keep you up to date on developments in the sector.
BioStock – Connecting Innovation & Capital.
Valet
Analytikernas råd


Aktieanalys
Valet
Analytikernas råd

Aktieanalys
1 DAG %
Senast


OMX Stockholm 30
0,32%
(vid stängning)
Fortum
Igår, 06:50
Fortum: AI-bubblan växer vidare
Krönika
11 september, 18:26
Valstriden om ISK: Partierna tävlar om nya skatteregler
Stockholmsbörsen
11 september, 17:44
Stockholmsbörsen stängde fredagen på grönt
Shipping
11 september, 16:15
Sjöfartsaktierna rusar – bäst på över tio år
OMX Stockholm 30
1 DAG %
Senast
3 255,23